<DOC>
	<DOCNO>NCT00963300</DOCNO>
	<brief_summary>RATIONALE : Diagnostic procedure , MRI , may help measure oxygen level tumor cell . It may also help doctor predict patient 's response treatment help plan best treatment . PURPOSE : This clinical trial study well MRI work assess hypoxia patient localized prostate cancer undergo stereotactic body radiation therapy .</brief_summary>
	<brief_title>MRI Assessing Hypoxia Patients With Localized Prostate Cancer Undergoing Stereotactic Body Radiation Therapy</brief_title>
	<detailed_description>OBJECTIVES : - To characterize status global hypoxia within prostate stereotactic body radiotherapy ( SBRT ) assess blood-oxygen-level-dependent tissue-oxygen-level-dependent MRI . - To characterize tumor vasculature metabolism within prostate SBRT assess dynamic contrast-enhanced MRI magnetic resonance spectroscopic imaging , respectively . - Correlate prostate normal tissue hypoxia SBRT clinical outcome ( toxicity biochemical [ PSA ] control ) SBRT . OUTLINE : Within 1-3 week begin stereotactic body radiotherapy , patient undergo T2-weighted anatomic MRI , magnetic resonance spectroscopic imaging , blood-oxygen-level-dependent tissue-oxygen-level-dependent MRI , dynamic contrast-enhanced MRI .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Biopsy proven adenocarcinoma prostate Localized disease Scheduled undergo treatment stereotactic body radiotherapy ( SBRT ) phase II clinical trial Has yet start SBRT PATIENT CHARACTERISTICS : Serum creatinine â‰¤ 1.2 mg/dL No claustrophobia No contraindication MRI ( e.g. , implant pacemaker device ) No know allergy MRI contrast PRIOR CONCURRENT THERAPY : No prior treatment prostate cancer ( e.g. , hormonal therapy chemotherapy )</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>adenocarcinoma prostate</keyword>
	<keyword>stage I prostate cancer</keyword>
	<keyword>stage IIB prostate cancer</keyword>
	<keyword>stage IIA prostate cancer</keyword>
	<keyword>stage III prostate cancer</keyword>
	<keyword>stage IV prostate cancer</keyword>
</DOC>